Xalud Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Xalud Therapeutics's estimated annual revenue is currently $6.7M per year.
- Xalud Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Xalud Therapeutics has 43 Employees.
- Xalud Therapeutics grew their employee count by 153% last year.
Xalud Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CMO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Financial Officer / Chief Operating Officer | Reveal Email/Phone |
4 | Chief Development Officer | Reveal Email/Phone |
5 | VP Research And Development | Reveal Email/Phone |
6 | SVP, Global Commercial Development | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | Chief Technology Officer | Reveal Email/Phone |
9 | Senior Director, Research and Development | Reveal Email/Phone |
10 | Chief Regulatory Officer, Head Quality | Reveal Email/Phone |
Xalud Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Xalud Therapeutics?
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.
keywords:N/A
N/A
Total Funding
43
Number of Employees
$6.7M
Revenue (est)
153%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xalud Therapeutics News
Xalud Therapeutics is a biotechnology company developing a DNA-delivered therapy platform to treat pathologic inflammation through immune...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.6M | 43 | -49% | $56.6M |
#2 | $4.7M | 43 | 5% | $28.3M |
#3 | $4.6M | 43 | -56% | $20.2M |
#4 | $4.8M | 43 | 23% | N/A |
#5 | $5M | 43 | -9% | N/A |